Clinical impact of pretreatment albumin–globulin ratio in patients with colorectal cancer

MLA

Ma, Jian-Ying, et al. “Clinical Impact of Pretreatment Albumin–globulin Ratio in Patients with Colorectal Cancer.” Medicine, vol. 101, no. 20, May 2022, p. e29190. EBSCOhost, https://doi.org/10.1097/MD.0000000000029190.

APA

Ma, J.-Y., Liu, G., Pan, L.-Z., Hu, M., Zhu, Z.-Z., & Pocha., C. (2022). Clinical impact of pretreatment albumin–globulin ratio in patients with colorectal cancer. Medicine, 101(20), e29190. https://doi.org/10.1097/MD.0000000000029190

Chicago

Ma, Jian-Ying, Gang Liu, Liang-Zhi Pan, Min Hu, Zhong-Zhong Zhu, and Christine Pocha. 2022. “Clinical Impact of Pretreatment Albumin–globulin Ratio in Patients with Colorectal Cancer.” Medicine 101 (20): e29190. doi:10.1097/MD.0000000000029190.